Vial Dedicated Phase I  Unit

Vial’s Dermatology Phase 1 unit provides a unified full service solution to early clinical development.

500+

Dermatology Clinical Trials

64

Phase 1 Studies

42

Indications

10,000+

Randomized Patients

Team

Phase 1 Units are critical to advancing care and validating treatments, that’s why it’s critical to have a Phase 1 Unit that you can rely on

Janet DuBois, MD

Medical Director, CRO

Dr. DuBois has overseen more than 200 trials and is a leading Dermatology PI

Karina Garcia

Site Director

Site Director Karina Garcia manages the 15-person research-only site and oversees all Phase 1 pre-planning and execution.

Capabilities

Confinement, Repeat PKs, ECG, and other timed procedures by experienced staff who can handle the complexity of overlapping subjects with multiple repeat procedures

Our Phase 1 research coordinators are IATA and CPR certified with 5-25 year of experience! They are familiar with multiple EDS and IWRS systems. All research coordinators complete annual GCP and NIH training as well as in-house reucurring training.

DRI’s 7,000 sq ft clinic

Case Study

One-site Phase 1 Actinic Keratosis study

One-site Phase 1 study initiated in February 2020 for Actinic Keratosis. Screened 48 and randomized 32 over a four month screening/ enrollment period. Study included multiple PK days (-1, -0.5, 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10 hrs) and overnight confinement. $15k ad budget.

Learn more about our Phase I Unit

Contact Us

Note: If you are looking to participate in a clinical trial, please click here
Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.